Background illustration for clinical trials search

Paid Clinical Trials Cleveland

Discover 1,399 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

for
Amblyopia
Location: Cleveland OH, Mayfield Heights OH, Erie PA, Columbus OH,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 8 - 12

Code: NCT06524882

Phase3, Recruiting

Clarifying the Optimal Application of SLT Therapy Trial

for
Glaucoma and Ocular Hypertension
Location: Cleveland OH, Detroit MI, Ann Arbor MI, Morgantown WV,
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT04967989

Phase3, Recruiting

Dextenza in the Post-op Management of Vitreoretinal Surgeries

for
Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain,
Location: Cleveland OH
Sponsor: The Cleveland Clinic

Sex: All

Age: 18+

Code: NCT04371445

Recruiting
New

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

for
Non Hodgkin Lymphoma, B-cell Non Hodgkin Lymphoma,
Location: Cleveland OH
Sponsor: Paolo Caimi, MD

Sex: All

Age: 18+

Code: NCT07225439

Phase1, Recruiting

Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression

for
High Grade Glioma, Glioblastoma
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05565118

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling

for
HER2-negative Breast Cancer
Location: Cleveland OH, Canton OH, Mount Vernon OH, Detroit MI,
Sponsor: NSABP Foundation Inc

Sex: Female

Age: 18+

Code: NCT03412643

Phase2, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Cleveland OH, Detroit MI, Ann Arbor MI, Columbus OH,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase1, Recruiting

Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases

for
Spine Metastases, Spine Stereotactic Radiosurgery (sSRS)
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT04218617

Phase2, Recruiting

Efficacy & Safety for LN144 with Pembrolizumab with High Risk Stage IIIb-dResectable Melanoma

for
Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IIID Melanoma
Location: Cleveland OH
Sponsor: James Isaacs, MD

Sex: All

Age: 18+

Code: NCT06190249

Phase1, Recruiting

The PREDICT Registry:

for
DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ
Location: Cleveland OH, Akron OH, Royal Oak MI, Troy MI,
Sponsor: PreludeDx

Sex: Female

Age: 30 - 70+

Code: NCT03448926

Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

for
Melanoma, Cutaneous Malignant
Location: Cleveland OH, Pittsburgh PA, Ann Arbor MI, Columbus OH,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT06743126

Phase3, Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Cleveland OH, Independence OH, Warrensville Heights OH,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase3, Recruiting

Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma

for
Lymphoma, Non-Hodgkin Lymphoma, B-Cell
Location: Cleveland OH
Sponsor: Luminary Therapeutics

Sex: All

Age: 18+

Code: NCT05312801

Phase1, Recruiting

Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer

for
Localized Muscle Invasive Bladder Urothelial Carcinoma,
Location: Cleveland OH
Sponsor: Shilpa Gupta, MD

Sex: All

Age: 18+

Code: NCT05833867

Phase1, Recruiting

Development of MRF for Characterization of Brain Tumors After Radiotherapy

for
Brain Tumor, Brain Necrosis, Brain Metastases, Glioma
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18 - 60

Code: NCT06101069

Recruiting

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

for
Ovarian Cancer, Breast Cancer, Endometrial Cancer,
Location: Cleveland OH, Pittsburgh PA, Buffalo NY, Edgewood KY,
Sponsor: NextCure, Inc.

Sex: All

Age: 18+

Code: NCT06774963

Phase1, Recruiting

Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation

for
Graft Vs Host Disease, Vulvovaginal Signs and Symptoms
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: Female

Age: 18 - 70

Code: NCT06649201

Recruiting

Sacituzumab Govitecan in Recurrent Glioblastoma

for
Recurrent Glioblastoma
Location: Cleveland OH, Austin TX, San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 18+

Code: NCT04559230

Phase2, Recruiting

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

for
Relapsed Sarcomas
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05210374

Phase1, Recruiting

Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

for
Non-Hodgkin Lymphoma, Cytokine Release Syndrome
Location: Cleveland OH
Sponsor: Taylor Brooks

Sex: All

Age: 18 - 65

Code: NCT06447376

Phase1, Recruiting